Arthritis – both osteoarthritis and rheumatoid arthritis – affects most adults over 50 and limits the activity of many. Pain drugs and supplements to ease pain can interact and cause health risks.

Research shows adults with rheumatoid arthritis are underprescribed disease-modifying drugs, despite guidelines saying otherwise. Clinicians must treat rheumatic diseases while addressing multimorbidity and polypharmacy.

When a father and his two kids developed an array of peculiar symptoms, doctors, Brazilian researchers and the NIH partnered to find a diagnosis and path to treatment.

Study in people taking a biologic drug for autoimmune diseases shows association of patient support programs with reduced chance of starting opioid pain medicines or continuing on them.

The new approach blocks the interaction between cancer cells and immune receptors, showing promise in mice.

The updated 2020 guidelines from the American College of Rheumatology focus on establishing a standard treat-to-target urate lowering therapy.

Managing arthritis symptoms may start in the kitchen, experts say. A rheumatologist provides tips and an easy recipe to help those with osteoarthritis and rheumatoid arthritis diagnoses.

Tripping on an uneven sidewalk did more than hurt Sharon Kinnunen’s knee. It brought worry as she feared seeking care at the height of the COVID-19 outbreak

Rare Disease Day is celebrated across the globe to raise awareness about rare diseases and how they impact patients’ lives. Michigan Medicine is working to better understand the mechanisms behind these rare diseases.

New autoimmune disorder research may provide clues as to why TNF inhibitors, the drugs used to treat these diseases, carry serious infection and cancer risks.

CBD oil and other supplements containing cannabidiol are gaining popularity, but does CBD work for treating chronic pain?

With numerous new and challenging obligations to face, the road to adulthood for kids and teens is anything but easy. Writer Helen Korneffel shares the latest findings from the C.S. Mott Children’s National Poll on Children’s Health.

These two diseases have similar early symptoms. A U-M rheumatologist sheds light on the two most common types of arthritis.

A new grant will allow Michigan Medicine researchers to explore personalized approaches to treating autoimmune diseases such as scleroderma, lupus, rheumatoid arthritis and others.

Treatment planning for a painful and potentially disabling condition could be made easier with a new model for assessing genetic risk in people with psoriasis.